Alligator Bioscience AB (ATORX)

Currency in SEK
0.0101
-0.0005(-4.72%)
Closed·

ATORX Earnings

Latest Release
Oct 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/----/------Free Sign Up
2026/06-0.060/--288.00K/------Free Sign Up
2026/030.000/--98.00K/------Free Sign Up
2025/12-0.660/--409.00K/------Free Sign Up
2025/09-0.340/--384.00K/------Free Sign Up
2025/06-0.080/--89.00K/------Free Sign Up
2025/03-1.11/--319.00K/------Free Sign Up
2024/12-73.10/--41.84M/------Free Sign Up
2024/09-2.14/--2.30M/------Free Sign Up
2024/06-1.42/-0.0607.90M/7.90M-2,266.67%0%Free Sign Up

All numbers in SEK

Alligator Bioscience AB Earnings Call Summary for Q3/2026

  • Alligator Bioscience pivots to royalty model, owns 35% of AbClon's HLX22 interest, yielding up to 1.75% effective royalty rate on net sales.
  • Company holds SEK 41M cash post-rights issue; targeting SEK 1M monthly operating costs by Q2 2027 amid workforce reduction and wind-down.
  • First royalty income not expected until 2030 or later; HLX22 phase III gastric cancer data anticipated second half 2027.
  • Current cash insufficient to reach royalty phase; company dependent on warrant exercises in Jan 2027 and Jan 2028 for additional funding.
  • Shares down 1.85% to $0.0106, near 52-week low; market cap just $0.67M reflects weak financial health score of 1.11 and high financing risk.
Last Updated: 2026-10-22, 08:40 a/m
Read Full Transcript

FAQ

What Is Alligator Bioscience's Earnings Per Share (TTM)?

The Alligator Bioscience EPS (TTM) is -0.18.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.